Last reviewed · How we verify
Blood transfusions
At a glance
| Generic name | Blood transfusions |
|---|---|
| Sponsor | Azienda Usl di Bologna |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Improving White Blood Cell Collection From Healthy Donors (PHASE4)
- Bevacizumab In Hereditary Hemorrhagic Telangiectasia (PHASE2)
- Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID) (PHASE1, PHASE2)
- Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy (NA)
- Canadian Critical Care Comparative Effectiveness Platform (PHASE3)
- Study of Transfusion-Transmitted Infections
- HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids (NA)
- Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |